• Intravenous Infusions is trading 9.1% up at $0.24, extending a sharp multi-day rally.
  • The surge follows recent reports that CCM Healthcare Investments FZCO acquired over 1 million shares of the company.
  • This Dubai-based healthcare investment firm plans to bring its expertise to support Intravenous Infusions.